MedTrace Logo

6 Minute Walk Test in Cystic Fibrosis

NCT02538575 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 291

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether the 6-minute walk test (6MWT) could be a prognostic factor for cystic fibrosis patients.

Conditions

Interventions

OTHER

6-minute walk test

a walk of 6 minutes repeated twice in an interval of 30 minutes

Sponsors & Collaborators

  • Data analysis : EFFI-STAT (statistic expert)

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Funding : Association Vaincre La Mucoviscidose

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Pierre-Regis BURGEL, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-12
Primary Completion
2018-12-06
Completion
2020-09-18

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02538575 on ClinicalTrials.gov